Immunosuppressive Psoriatic Drugs Don't Increase Risks for COVID-19 Complications

June 13th 2020, 2:00pm


Authors of an opinion piece concluded that not only are immunosuppressed patients with psoriasis not at an increased risk of developing serious complications related to coronavirus disease 2019 (COVID-19), their medications may help mitigate potential issues.

What Is the Impact of Psoriasis on Patients' Mental Health?

June 12th 2020, 1:06am


Patients with psoriasis often have other physical diseases, and these somatic comorbidities can have a bigger effect on the patient’s mental health than the skin symptoms from their psoriasis, according to a study published in JAMA Dermatology.

Real-World Study Examines Treatment Patterns of 2 Biologics for Psoriasis

June 5th 2020, 9:57pm


The study looked at patients taking ixekizumab or adalimumab.

Global Burden of Psoriasis Has Risen for 3 Decades

June 3rd 2020, 5:00pm


A global epidemiological study on psoriasis has found that the prevalence, incidence, and burden of suffering caused by the disease has risen over the last 3 decades.

Examining the Prevalence of Obesity and Depression Among Patients With Psoriasis on Biologics

May 30th 2020, 7:00pm


Use of biologics to treat psoriasis may impact prevalence of comorbidities like depression and obesity, according to an abstract presented at the Virtual 2020 International Society for Pharmacoeconomics and Outcomes Research meeting.

Analysis Shows How Pandemic Led to Worsened Conditions for Patients With Psoriasis

May 30th 2020, 5:54pm


A recent analysis describes the effects of the pandemic, including restrictions on outdoor activities and loss of income, on patients with psoriasis in China earlier this year.

Gap Remains in Identifying Patients With Psoriasis Likely to Develop Psoriatic Arthritis

May 29th 2020, 1:51am


Despite some clues, scientists don’t yet understand which patients with psoriasis are likely to eventually develop psoriatic arthritis; solving that riddle could have major impacts on patient care.

Psoriatic Arthritis Leads to Higher Costs, Absenteeism, Studies Say

May 23rd 2020, 9:11pm


Psoriatic arthritis and psoriasis both place a significant economic burden on patients, but a new analysis shows the burden on people with the former is significantly higher.

Sociodemographic Factors Influence Outcomes Among Patients With Psoriasis

May 22nd 2020, 9:56pm


A patient’s sex, disease duration, and residence were the most common sociodemographic factors shown to affect illness acceptance, life satisfaction, sense of stigmatization, and quality of life among those who have psoriasis, according to the results of a recent study.

Virtual ISPOR Panel to Examine Next Steps in Value Assessment

May 18th 2020, 12:20am


Two of the panelists appearing during the Virtual ISPOR 2020 meeting preview what's needed in improving value assessment: Lou Garrison, PhD, of the University of Washington, and Leah Howard, JD, of the National Psoriasis Foundation.